BBSRC Portfolio Analyser
Award details
Somatostatin receptors and brain function
Reference
BBS/E/B/47916367
Principal Investigator / Supervisor
Dr Piers Emson
Co-Investigators /
Co-Supervisors
Institution
Babraham Institute
Department
Babraham Institute Department
Funding type
Research
Value (£)
20,926
Status
Completed
Type
Institute Project
Start date
01/10/1997
End date
31/03/2000
Duration
30 months
Abstract
This project aims to explore the function of somatostatin in the CNS by making and examining mice deficient in various isoforms of the somatostatin receptor. Mice are being produced in the Institute and this studentship will examine these in detail using anatomical, pharmacological and behavioural tests. Somatostatin was originally discovered as growth hormone release inhibitory factor, however subsequent work has shown that this neuropeptide is widely distributed in the CNS and may play a role in cognitive function and pain perception as well as functioning as a hypothalamic releasing factor. In the Institute in collaboration with Glaxo-Wellcome null mutant mice are being made for various somatostatin receptors. This studentship will use available tools in situ pulses/antibodies to characterise KO mice as they are developed. Pharmacological assays for receptor function (or lack of it) will be carried out in the Glaxo Institute of Applied Pharmacology, University Department of Pharmacology. The student will have the opportunity to create their own KO mouse and also to attempt to clone a human variant of one of the isoforms. The project provides a broad training in modern cellular and biological techniques.
Summary
unavailable
Committee
Closed Committee - Animal Sciences (AS)
Research Topics
X – not assigned to a current Research Topic
Research Priority
X – Research Priority information not available
Research Initiative
X - not in an Initiative
Funding Scheme
X – not Funded via a specific Funding Scheme
I accept the
terms and conditions of use
(opens in new window)
export PDF file
back to list
new search